These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1188 related articles for article (PubMed ID: 32768313)

  • 1. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis.
    Yoshida N; Iino Y
    Allergol Int; 2014 Dec; 63(4):523-32. PubMed ID: 25339433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis.
    Hosokawa Y; Okada M; Suemori K; Hamaguchi N; Miyoshi KI; Takagi T; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hato N
    Auris Nasus Larynx; 2021 Oct; 48(5):885-889. PubMed ID: 33589280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Localized and Systemic Otitis Media With ANCA-Associated Vasculitis.
    Okada M; Suemori K; Takagi D; Teraoka M; Yamada H; Hato N
    Otol Neurotol; 2017 Dec; 38(10):e506-e510. PubMed ID: 28885482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Otologic Manifestations in Patients with ANCA Associated Vasculitis-Comparative Analysis among Microscopic Polyangiitis, Granulomatosis with Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis].
    Kawashima Y; Noguchi Y; Ito T; Mizushima K; Takahashi M; Kitamura K; Tsutsumi T
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):110-7. PubMed ID: 27149708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Dobashi H; Takasaki Y; Ito S; Yamada H; Wada T; Hirahashi J; Arimura Y; Makino H;
    Arthritis Res Ther; 2014 Apr; 16(2):R101. PubMed ID: 24758294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
    J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otitis media with ANCA-associated vasculitis: A retrospective study of 30 patients.
    Tabei A; Sakairi T; Ohishi Y; Watanabe M; Nakasatomi M; Hamatani H; Ikeuchi H; Kaneko Y; Hiromura K
    Mod Rheumatol; 2022 Aug; 32(5):923-929. PubMed ID: 34915561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aural Manifestations of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis-Diagnosis, Symptoms, Treatment.
    Kaczmarczyk MS; Jurkiewicz D; Niemczyk S; Rymarz A
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Beketova TV
    Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature.
    Ono N; Yoshihiro K; Oryoji D; Matsuda M; Ueki Y; Uezono S; Kai Y; Himeji D; Niiro H; Ueda A
    Mod Rheumatol; 2013 May; 23(3):554-63. PubMed ID: 22706878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
    Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
    Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
    Shimojima Y; Sekijima Y
    Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV).
    Morita Y; Kitazawa M; Yagi C; Nonomura Y; Takahashi K; Yamagishi T; Ohshima S; Izumi S; Horii A
    Auris Nasus Larynx; 2020 Oct; 47(5):740-746. PubMed ID: 32173171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
    Singh D; Sukumaran S
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hearing prognosis of otitis media with ANCA-associated vasculitis.
    Iwata S; Okada M; Suemori K; Teraoka M; Yamada H; Ishizaki J; Matsumoto T; Hato N
    Auris Nasus Larynx; 2021 Jun; 48(3):377-382. PubMed ID: 32951931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.